Company: BIAF
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010787
Chunk: 22

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 7
Chunk 22
---
 formatted in Inline XBRL
  
    101.INS
     
    Inline XBRL Instance Document *
  
    101.SCH
     
    Inline XBRL Taxonomy Extension Schema Document *
  
    101.CAL
     
    Inline XBRL Taxonomy Extension Calculation Linkbase *
  
    101.DEF
     
    Inline XBRL Taxonomy Extension Definition Linkbase Document *
  
    101.LAB
     
    Inline XBRL Taxonomy Extension Label Linkbase Document *
  
    101.PRE
     
    Inline XBRL Taxonomy Extension Presentation Linkbase Document *

* Filed herewith.

† Indicates
management contract or compensatory plan.

27

SIGNATURES

Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

    BIOAFFINITY TECHNOLOGIES, INC.

    (Registrant)

    By:
    /s/ Maria Zannes

    Maria Zannes

    Chief Executive Officer, President, Founder, and Director

    Date:
    May 15, 2025

    By:
    /s/ J. Michael Edwards

    J. Michael Edwards
    Vice President and Chief Financial Officer

    Date:
    May 15, 2025

28